First Light Asset Management, LLC Mirum Pharmaceuticals, Inc. Transaction History

First Light Asset Management, LLC

  • $1.15 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$19.98 - $29.44 $4.9 Million - $7.22 Million
245,190 Added 88.3%
522,864 $11 Million
Q2 2022

Aug 12, 2022
BUY
$18.42 - $27.5 $1.15 Million - $1.72 Million
62,635 Added 29.13%
277,674 $5.4 Million
Q1 2022

May 13, 2022
BUY
$15.5 - $23.93 $3.33 Million - $5.15 Million
215,039 New
215,039 $4.74 Million

Others Institutions Holding MIRM

# of Institutions
193
Shares Held
54M
Call Options Held
177K
Put Options Held
167K
View Full List

About Mirum Pharmaceuticals, Inc.

MIRM Quotes by TradingView
  • Ticker MIRM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,751,700
  • Market Cap $1.8B
  • Description
  • Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...
More about MIRM
Track This Portfolio

Track First Light Asset Management, LLC Portfolio

Follow First Light Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Light Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on First Light Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email